These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 14023830

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [HEMOSTATIC TRANSFUSION PREPARATIONS PREPARED FROM DONOR BLOOD (ANTIHEMOPHILIC PLASMA, ANTIHEMOPHILIC GLOBULIN, FIBRINOGEN)].
    ROZENBERG GIa, RUDNITSKAIA MZ.
    Probl Gematol Pereliv Krovi; 1963 Jun; 8():3-9. PubMed ID: 14070543
    [No Abstract] [Full Text] [Related]

  • 3. [PLASMA TRANSFUSION IN HEMOPHILIA. IX. EXPERIENCE WITH 2-DONOR FIBRINOGEN].
    VAN CREVELD, MOCHTAR IA, KOPPE JG.
    Ned Tijdschr Geneeskd; 1963 Sep 28; 107():1736-9. PubMed ID: 14050958
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [THE SUPPLY OF PERSONALLY PREPARED PLASMA FRACTIONS IN HEMOPHILIA A].
    GAERISCH F.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1963 Sep 28; 81():148-55. PubMed ID: 14165084
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of classic hemophilia: the use of fibrinogen rich in factor VIII for hemorrhage and for surgery.
    MCMILLAN CW, DIAMOND LK, SURGENOR DM.
    N Engl J Med; 1961 Aug 10; 265():277-83 concl. PubMed ID: 13774141
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The safe blood components for a hemophilia patient: a case report.
    Chuansumrit A, Pandhawong S, Tardtong P, Isarangkura P.
    Southeast Asian J Trop Med Public Health; 1993 Aug 10; 24 Suppl 1():198-200. PubMed ID: 7886573
    [Abstract] [Full Text] [Related]

  • 12. Use of blood products and factor concentrates for coagulation therapy.
    Fritsma MG.
    Clin Lab Sci; 2003 Aug 10; 16(2):115-9. PubMed ID: 12757192
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Principles of using blood preparation in children with hemophilia and other congenital hemorrhagic disorders].
    Adamowicz-Salach A, Kamińskka D, Jakubowska M, Gregosiewicz A, Rokicka-Milewska R.
    Pediatr Pol; 1988 May 10; 63(5):273-8. PubMed ID: 3146055
    [No Abstract] [Full Text] [Related]

  • 16. [EXPERIMENTS CONCERNING FACTOR 8. LONGEVITY OF FACTOR 8 IN VIVO AND VITRO AND THE SUBFRACTIONATION OF FIBRINOGEN SAMPLES FROM 2 DONORS].
    MOCHTAR IA, KOPPE JG, STIBBE J.
    Maandschr Kindergeneeskd; 1964 Jul 10; 32():440-5. PubMed ID: 14228685
    [No Abstract] [Full Text] [Related]

  • 17. [Therapy of hemophilia and its social aspects].
    Digilio G.
    Minerva Pediatr; 1967 Nov 03; 19(44):1963-9. PubMed ID: 5616636
    [No Abstract] [Full Text] [Related]

  • 18. [Spontaneous splenic rupture in a child with hemophilia].
    Gruminskiĭ VS, Grechanyĭ VP.
    Vestn Khir Im I I Grek; 1990 Apr 03; 144(4):69-70. PubMed ID: 2173236
    [No Abstract] [Full Text] [Related]

  • 19. [Various methods for good blood supply in Scandinavia].
    Oldinger E.
    Nord Med; 1996 Sep 03; 111(7):212-8. PubMed ID: 8927533
    [No Abstract] [Full Text] [Related]

  • 20. [Results of in vivo analysis of injected fibrinogen degradation products and factor VIII in patients with hemophilia A].
    Kätzel R, Kubel M, Scheel H, Wegner H.
    Z Gesamte Inn Med; 1978 Aug 01; 33(15):525-9. PubMed ID: 695793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.